刺激反应性聚合体:重塑免疫抑制性瘤微环境
Yaohua Wei1, Xiao Weng2, Yayun Wang2
1CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.
Biomacromolecules
|July 26, 2024
概括
刺激反应性聚合体通过精确向瘤和增强抗瘤免疫力,提供先进的癌症治疗. 这些纳米粒子可以携带多种药物,减少副作用,并重塑瘤微环境以获得更好的治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症研究 癌症研究
背景情况:
- 癌症的进展涉及复杂的瘤微环境 (TMEs) 和不受控制的细胞分裂.
- 免疫疗法看起来很有前途,但在平衡有效性和安全性方面面临挑战.
- 纳米粒子,特别是聚合体,为癌症治疗提供有针对性的药物输送和免疫调节.
研究的目的:
- 审查刺激响应性聚合体在癌症治疗中的最新进展.
- 突出其在重塑瘤微环境和增强抗瘤免疫力的潜力.
- 讨论聚合体在临床翻译中的优势,局限性,挑战和未来前景.
主要方法:
- 对癌症治疗中刺激反应性聚合体的当前文献的综述.
- 对聚合体机制的分析,包括药物输送,免疫激活 (STING通路) 和免疫细胞死亡.
- 评估聚合体在调节瘤微环境中的作用.
主要成果:
- 刺激响应的聚合体可以精确地准瘤并提供多种治疗方法.
- 这些纳米颗粒可以诱导免疫细胞死亡并激活STING通路,增强抗瘤免疫力.
- 聚合体在减少与传统癌症疗法相关的副作用方面显示出潜力.
结论:
- 刺激响应的聚合体是先进的癌症治疗的有希望的平台.
- 需要进一步的研究和临床转化,以充分利用其在重塑TME和改善患者结果方面的潜力.
- 开发具有多疗效的携带聚合体的方法为克服癌症复杂性的治疗提供了战略方法.
更多相关视频
相关概念视频
Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cell-mediated Immune Responses
68.0K
Overview
68.0K


